Gene · 7804
Papers1,602
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,602
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted extracellular degradation of LRP8 promotes ferroptosis in cancer cells. | Proc Natl Acad Sci U S A | 2026 | 42814555 | PubTator, text mining | PubMed |
| Dual CHK1 and WNT Inhibition as a Synergistic Therapy for Gastrointestinal Neuroendocrine Carcinoma. | Cancer Res Commun | 2026 | 42811518 | PubTator, text mining | PubMed |
| Resident tissue macrophages transfer selenium transporter protein to protect pancreatic cancer from ferroptosis. | Cell | 2026 | 42785301 | PubTator, text mining | PubMed |
| Alternative splicing in Alzheimer's disease: event-level evidence, risk-locus biology, and RNA-based therapeutic perspectives. | Gene | 2026 | 42744164 | PubTator, text mining | PubMed |
| Apolipoprotein E in Alzheimer's disease: A review of APOE receptors, signalling pathways and therapeutic opportunities. | Mol Cell Neurosci | 2026 | 42362005 | PubTator, text mining | PubMed |
| Targeting ACKR3/CXCR7 enhances platelet anticoagulant acylcarnitines and modulates procoagulant function. | Blood | 2026 | 42296019 | PubTator, text mining | PubMed |
| LRP4 is an entry receptor for multiple encephalitic alphaviruses. | Nat Commun | 2026 | 42265108 | PubTator, text mining | PubMed |
| Role of Hyperlipidemia-Related PCSK9, APOE, and LRP8 Variants in Restenosis after Stent Implantation in Male Patients: A Case-Control Study. | Mol Syndromol | 2026 | 42253317 | PubTator, text mining | PubMed |
| Targeted extracellular degradation of LRP8 promotes ferroptosis in cancer cells. | bioRxiv | 2026 | 42239248 | PubTator, text mining | PubMed |
| Novel mechanisms linking platelet activation to antiphospholipid syndrome. | Curr Opin Immunol | 2026 | 42214306 | PubTator, text mining | PubMed |
| sh-lncRNA-SNHG4 Regulates Cell Proliferation, Apoptosis, and EMT in Osteosarcoma Cells via Regulating miR-204-5p to Target LRP8. | Comb Chem High Throughput Screen | 2026 | 42163624 | PubTator, text mining | PubMed |
| The Reelin-L1CAM Signalling Axis: Orchestrating Molecular Synergy in Neural Repair and Regeneration. | Int J Dev Neurosci | 2026 | 42037390 | PubTator, text mining | PubMed |
| Identification of LRP8 as a potential therapeutic target for irritable bowel syndrome from the proteomes of plasma and cerebrospinal fluid in a Mendelian randomization study. | Rev Esp Enferm Dig | 2026 | 42024114 | PubTator, text mining | PubMed |
| Genome-wide association study reveals genetic loci associated with body shape related traits in Takifugu bimaculatus. | Comp Biochem Physiol Part D Genomics Proteomics | 2026 | 41934866 | PubTator, text mining | PubMed |
| Generation and validation of C-terminal LRP8 antibodies for detecting processed intracellular fragments. | Biotechniques | 2026 | 41916355 | PubTator, text mining | PubMed |
| The Self-amplifying Inflammatory Cascade in Obstetric Antiphospholipid Syndrome: From Pathophysiology to Placenta-centric Immunotherapeutic Targets. | Clin Rev Allergy Immunol | 2026 | 41912780 | PubTator, text mining | PubMed |
| The Crimean-Congo haemorrhagic fever virus hijacks the liver lipid metabolic pathway for virion production. | Emerg Microbes Infect | 2026 | 41911362 | PubTator, text mining | PubMed |
| Genetic Architecture of Cognitive Resilience in Alzheimer's Disease: Mechanisms, Pathways, and Therapeutic Implications. | Neurol Int | 2026 | 41893052 | PubTator, text mining | PubMed |
| Architects of the Developing Brain: Cytoskeleton-Organizing Molecules in Neurodevelopmental Disorders. | Cells | 2026 | 41892327 | PubTator, text mining | PubMed |
| Salinomycin as a death switch: how gastric cancer cells choose their demise. | Cell Death Discov | 2026 | 41876479 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7804/papers